Your Health Plan:
Your Health Plan:
Not SelectedSKYRIZI (risankizumab) is a biologic prescription drug for treatment of Arthritis, Psoriatic and Crohn Disease. SKYRIZI is a interleukin-23 antagonist. It is available in the form of subcutaneous injection / subcutaneous injection / intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $10800-19800.
Patient Assistance Prorgams and Coupons are found: